Last $0.36 HKD
Change Today 0.00 / 0.00%
Volume 0.0
2327 On Other Exchanges
Hong Kong
As of 4:01 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

u-home group holdings ltd (2327) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/19/13 - $0.65
52 Week Low
05/19/14 - $0.26
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for U-HOME GROUP HOLDINGS LTD (2327)

Related News

No related news articles were found.

u-home group holdings ltd (2327) Related Businessweek News

No Related Businessweek News Found

u-home group holdings ltd (2327) Details

U-Home Group Holdings Limited, an investment holding company, is primarily engaged in trading pharmaceutical and health care products in Hong Kong and the People's Republic of China. It is also involved in the research and development of chemical and biological products; investment and treasury function; and provision of property agency and consultancy services. The company was formerly known as Jiwa Bio-Pharm Holdings Limited and changed its name to U-Home Group Holdings Limited in November 2013. The company is headquartered in Kowloon, Hong Kong. U-Home Group Holdings Limited is a subsidiary of U-Home Group International Limited.

7 Employees
Last Reported Date: 06/26/14

u-home group holdings ltd (2327) Top Compensated Officers

Vice Chairman and Chief Executive Officer
Total Annual Compensation: $100.0K
Chairman and Chairman of Nomination Committee
Total Annual Compensation: $292.0K
Executive Director and Member of Remuneration...
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2014.

u-home group holdings ltd (2327) Key Developments

U-Home Group Holdings Limited, Special/Extraordinary Shareholders Meeting, Jul 29, 2014

U-Home Group Holdings Limited, Special/Extraordinary Shareholders Meeting, Jul 29, 2014., at 10:45 China Standard Time. Location: Room 3, United Conference Centre. Agenda: To approve the framework agreement dated May 19, 2014 between U-Home Group Limited and Nanjing Tuoyu; and to authorize any one director, or any two directors if the affixation of the common seal is necessary, of the company to do all such further acts and things and execute such further documents for and on behalf of the company.

U-Home Group Holdings Limited Announces Change of Address of Principal Place of Business in Hong Kong

The Board of Directors of U-Home Group Holdings Limited hereby announced that the company's principal place of business in Hong Kong has been relocated to Unit 2906, Tower 1, Lippo Centre, 89 Queensway, Admiralty, Hong Kong with effect from 1 July 2014.

U-Home Group Holdings Limited Announces Audited Consolidated Cash Flow Results for the Year Ended March 31, 2014

U-Home Group Holdings Limited announced audited consolidated cash flow results for the year ended March 31, 2014. For the period, the company reported net cash generated from operating activities of HKD 71,595,000 compared to HKD 51,094,000 a year ago. Payments for purchase of property, plant and equipment were HKD 68,000 compared to HKD 112,000 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2327:HK $0.36 HKD 0.00

2327 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2327.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2327 Industry Range
Price/Earnings 6.6x
Price/Sales 16.8x
Price/Book 6.2x
Price/Cash Flow 6.6x
TEV/Sales 12.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact U-HOME GROUP HOLDINGS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at